1Klatshin G. Adenocarcinoma of the hepatic duct at the bifurcation within the porta hepatitis: an unususal tumor with distinctive clinical and pathological features[ J ]. Am J Med, 1965, 38: 241-256.
2Nishio H, Kamiya J, Nagino M, et al, Value of percutaneous transhepatic portography before hepatecomy for helar cholangiocarinoma[J].Br J Surg, 1999, 86(11) : 1415-1421.
3Mezawa S, Homma H, Sato T, et al. A study of carboplatin - coated tube for the unresectable cholangiocarcioma [ J ]. Hepatology, 2000, 32(5) :916-923.
5Taieb J, Mitry E, Boige V, et al. Optimization of 5 - fluomuracil/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-Fu and cisplatin( LVSFU2- P regimen) in patients with biliary trace carcinoma[J]. Ann Oncol, 2002, 13(8) : 1192-1196.
6Kim TW, Chang HM, Kang HJ, et al. Phase Ⅱ study of capecitabine plus clsplatin as first - line chemotherapy in advanced biliary cancer[ J ].Ann Oncol,2003, 14(7) : 1115-1120.
7Kuhn R, Hribaschek A, Eichelmann K, et al. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio - carcinomas[J]. Invest New Drugs, 2002, 20(3):351-356.
